RHI
44
4
FFIV
60
2
DOV
44
3
PEG
60
3
V
58
2
DAL
50
3
MAT
47
4
CI
38
5
WMB
62
2
IBM
48
4
FITB
30
2
HRL
42
-2
GE
61
6
FOX
75
5
USB
54
4
AMZN
55
4
MA
48
-2
XEL
50
-3
PPL
49
2
MAS
40
4
RHI
44
4
FFIV
60
2
DOV
44
3
PEG
60
3
V
58
2
DAL
50
3
MAT
47
4
CI
38
5
WMB
62
2
IBM
48
4
FITB
30
2
HRL
42
-2
GE
61
6
FOX
75
5
USB
54
4
AMZN
55
4
MA
48
-2
XEL
50
-3
PPL
49
2
MAS
40
4
Financhill
Back

Kronos Bio 10K Form

Sell
34

KRON
Kronos Bio

Last Price:
$0.96
Seasonality Move:
-12.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KRON News And Ratings

See the #1 stock for the next 7 days that we like better than KRON

KRON Financial Statistics

Sales & Book Value

Annual Sales: $6.3M
Cash Flow: $-12.4M
Price / Cash Flow: 0
Annual Sales: $1.84
Price / Book: 0.54

Profitability

EPS (TTM): -1.43000
Net Income (TTM): $-85.6M
Gross Margin: --
Return on Equity: -60.36%
Return on Assets: -45.11%

Kronos Bio Earnings Forecast

Key Kronos Bio Financial Ratios

  • The Research & Development expenses have been 1,373.71% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Kronos Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KRON
CUSIP: 50107A
Website: kronosbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.32
Quick Ratio: 8.12

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KRON Technical Analysis vs Fundamental Analysis

Sell
34
Kronos Bio (KRON) is a Sell

Is Kronos Bio a Buy or a Sell?

  • Kronos Bio stock is rated a Sell
    The current Kronos Bio [KRON] share price is $1.00. The Score for KRON is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.